Chemical biology approaches to target validation in cancer

被引：29

作者：

Blagg, Julian ^{[1
]}

Workman, Paul ^{[1
]}

机构：

[1] Inst Canc Res, Canc Res UK Canc Therapeut Unit, London SW3 6JB, England

来源：

CURRENT OPINION IN PHARMACOLOGY | 2014年 / 17卷

关键词：

SMALL-MOLECULE INHIBITOR; DRUG DISCOVERY; IDENTIFICATION; POTENT; CELLS; PROBE; RAS; PROTEINS; REVEALS; BIND;

D O I：

10.1016/j.coph.2014.07.007

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Target validation is a crucial element of drug discovery. Especially given the wealth of potential targets emerging from cancer genome sequencing and functional genetic screens, and also considering the time and cost of downstream drug discovery efforts, it is essential to build confidence in a proposed target, ideally using different technical approaches. We argue that complementary biological and chemical biology strategies are essential for robust target validation. We discuss recent progress in the discovery and application of high quality chemical tools and other chemical biology approaches to target validation in cancer. Among other topical examples, we highlight the emergence of designed irreversible chemical tools to study potential target proteins and oncogenic pathways that were hitherto regarded as poorly druggable.

引用

页码：87 / 100

页数：14

共 111 条

[1] Combinatorial drug therapy for cancer in the post-genomic era [J].

Al-Lazikani, Bissan ;

Banerji, Udai ;

Workman, Paul .

NATURE BIOTECHNOLOGY, 2012, 30 (07) :679-691

[2] Signatures of mutational processes in human cancer [J].

Alexandrov, Ludmil B. ;

Nik-Zainal, Serena ;

Wedge, David C. ;

Aparicio, Samuel A. J. R. ;

Behjati, Sam ;

Biankin, Andrew V. ;

Bignell, Graham R. ;

Bolli, Niccolo ;

Borg, Ake ;

Borresen-Dale, Anne-Lise ;

Boyault, Sandrine ;

Burkhardt, Birgit ;

Butler, Adam P. ;

Caldas, Carlos ;

Davies, Helen R. ;

Desmedt, Christine ;

Eils, Roland ;

Eyfjord, Jorunn Erla ;

Foekens, John A. ;

Greaves, Mel ;

Hosoda, Fumie ;

Hutter, Barbara ;

Ilicic, Tomislav ;

Imbeaud, Sandrine ;

Imielinsk, Marcin ;

Jaeger, Natalie ;

Jones, David T. W. ;

Jones, David ;

Knappskog, Stian ;

Kool, Marcel ;

Lakhani, Sunil R. ;

Lopez-Otin, Carlos ;

Martin, Sancha ;

Munshi, Nikhil C. ;

Nakamura, Hiromi ;

Northcott, Paul A. ;

Pajic, Marina ;

Papaemmanuil, Elli ;

Paradiso, Angelo ;

Pearson, John V. ;

Puente, Xose S. ;

Raine, Keiran ;

Ramakrishna, Manasa ;

Richardson, Andrea L. ;

Richter, Julia ;

Rosenstiel, Philip ;

Schlesner, Matthias ;

Schumacher, Ton N. ;

Span, Paul N. ;

Teague, Jon W. .

NATURE, 2013, 500 (7463) :415-+

[3] Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer [J].

Ali, Khaled ;

Soond, Dalya R. ;

Pineiro, Roberto ;

Hagemann, Thorsten ;

Pearce, Wayne ;

Lim, Ee Lyn ;

Bouabe, Hicham ;

Scudamore, Cheryl L. ;

Hancox, Timothy ;

Maecker, Heather ;

Friedman, Lori ;

Turner, Martin ;

Okkenhaug, Klaus ;

Vanhaesebroeck, Bart .

NATURE, 2014, 510 (7505) :407-+

[4]

[Anonymous], NATURE

[5]

[Anonymous], 2013, Oncogene

[6] Epigenetic protein families: a new frontier for drug discovery [J].

Arrowsmith, Cheryl H. ;

Bountra, Chas ;

Fish, Paul V. ;

Lee, Kevin ;

Schapira, Matthieu .

NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (05) :384-400

[7] STK33 Kinase Activity Is Nonessential in KRAS-Dependent Cancer Cells [J].

Babij, Carol ;

Zhang, Yihong ;

Kurzeja, Robert J. ;

Munzli, Anke ;

Shehabeldin, Amro ;

Fernando, Manory ;

Quon, Kim ;

Kassner, Paul D. ;

Ruefli-Brasse, Astrid A. ;

Watson, Vivienne J. ;

Fajardo, Flordeliza ;

Jackson, Angela ;

Zondlo, James ;

Sun, Yu ;

Ellison, Aaron R. ;

Plewa, Cherylene A. ;

San Miguel, Tisha ;

Robinson, John ;

McCarter, John ;

Schwandner, Ralf ;

Judd, Ted ;

Carnahan, Josette ;

Dussault, Isabelle .

CANCER RESEARCH, 2011, 71 (17) :5818-5826

[8] Genome-wide Profiling of Genetic Synthetic Lethality Identifies CDK12 as a Novel Determinant of PARP1/2 Inhibitor Sensitivity [J].

Bajrami, Ilirjana ;

Frankum, Jessica R. ;

Konde, Asha ;

Miller, Rowan E. ;

Rehman, Farah L. ;

Brough, Rachel ;

Campbell, James ;

Sims, David ;

Rafiq, Rumana ;

Hooper, Sean ;

Chen, Lina ;

Kozarewa, Iwanka ;

Assiotis, Ioannis ;

Fenwick, Kerry ;

Natrajan, Rachael ;

Lord, Christopher J. ;

Ashworth, Alan .

CANCER RESEARCH, 2014, 74 (01) :287-297

[9] Chemoproteomic approaches to drug target identification and drug profiling [J].

Bantscheff, Marcus ;

Drewes, Gerard .

BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (06) :1973-1978

[10] Target identification for a Hedgehog pathway inhibitor reveals the receptor GPR39 [J].

Bassilana, Frederic ;

Carlson, Adam ;

DaSilva, Jennifer A. ;

Grosshans, Bianka ;

Vidal, Solange ;

Beck, Valerie ;

Wilmeringwetter, Barbara ;

Llamas, Luis A. ;

Showalter, Todd B. ;

Rigollier, Pascal ;

Bourret, Aaron ;

Ramamurthy, Arun ;

Wu, Xu ;

Harbinski, Fred ;

Plonsky, Samantha ;

Lee, Lac ;

Ruffner, Heinz ;

Grandi, Paola ;

Schirle, Markus ;

Jenkins, Jeremy ;

Sailer, Andreas W. ;

Bouwmeester, Tewis ;

Porter, Jeffrey A. ;

Myer, Vic ;

Finan, Peter M. ;

Tallarico, John A. ;

Kelleher, Joseph F., III ;

Seuwen, Klaus ;

Jain, Rishi K. ;

Luchansky, Sarah J. .

NATURE CHEMICAL BIOLOGY, 2014, 10 (05) :343-+

← 1 2 3 4 5 6 7 8 9 10 →